Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. May 28, 2014; 20(20): 6262-6278
Published online May 28, 2014. doi: 10.3748/wjg.v20.i20.6262
Published online May 28, 2014. doi: 10.3748/wjg.v20.i20.6262
Treatment | Description |
Biochemical | Normalization of serum ALT |
Virological | |
HBeAg-positive | Loss of HBeAg, Anti-HBe antibodies, serum HBV-DNA < 2000 IU/mL |
HBeAg-negative | Serum HBV-DNA < 2000 IU/mL |
Complete | Biochemical and virological response with loss of serum HBsAg |
Histological | Decrease in necroinflammatory activity without worsening in fibrosis |
- Citation: Tang CM, Yau TO, Yu J. Management of chronic hepatitis B infection: Current treatment guidelines, challenges, and new developments. World J Gastroenterol 2014; 20(20): 6262-6278
- URL: https://www.wjgnet.com/1007-9327/full/v20/i20/6262.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i20.6262